Related Experiment Video
Updated: May 4, 2026
09:37
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
14.4K
Is it tea time for portal hypertension?
Jordi Gracia-Sancho1, Jaime Bosch1
1*Barcelona Hepatic Hemodynamic Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Clinical Science (London, England : 1979)
|December 21, 2013
Summary
Green tea polyphenols (GTPs) show promise in treating liver cirrhosis complications. Long-term GTPs intake reduced portal hypertension by decreasing liver resistance and hyperdynamic circulation, potentially via inhibiting blood vessel growth.
Area of Science:
- Hepatology
- Gastroenterology
- Pharmacology
Background:
- Portal hypertension is a major complication of liver cirrhosis and a leading cause of mortality in chronic liver disease.
- Effective treatments must address elevated hepatic resistance and hyperdynamic circulation, the core mechanisms of portal hypertension.
Purpose of the Study:
- To investigate the therapeutic effects of green tea polyphenols (GTPs) on portal hypertension in the context of liver cirrhosis.
- To elucidate the underlying mechanisms by which GTPs may ameliorate portal hypertension.
Main Methods:
- Long-term administration of GTPs to a model of cirrhosis and portal hypertension.
- Assessment of hepatic resistance and splanchnic hyperdynamic circulation.
- Evaluation of splanchnic angiogenesis as a potential mechanism.
Main Results:
- Long-term GTPs administration inhibited the development of cirrhosis and portal hypertension.
- GTPs significantly decreased both hepatic resistance and splanchnic hyperdynamic circulation.
- The beneficial effects of GTPs were associated with down-regulation of splanchnic angiogenesis.
Conclusions:
- Green tea polyphenols demonstrate a beneficial effect in improving portal hypertension associated with liver cirrhosis.
- GTPs may act by reducing hepatic resistance, splanchnic hyperdynamic circulation, and inhibiting angiogenesis.
- Natural compounds like GTPs offer potential as a nutraceutical approach for managing cirrhosis patients.
More Related Videos
Related Concept Videos
01:22Portal Hypertension
50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
01:24Esophageal Varices-I: Introduction
2.4K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.4K
01:28Esophageal Varices-II: Clinical Features and Management
884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
01:29Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
01:21Hepatic Portal System
8.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
8.2K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K